Literature DB >> 21550388

Effect of wheat germ agglutinin density on cellular uptake and toxicity of wheat germ agglutinin conjugated PEG-PLA nanoparticles in Calu-3 cells.

Yehong Shen1, Jie Chen, Qingfeng Liu, Chengcheng Feng, Xiaoling Gao, Lu Wang, Qizhi Zhang, Xinguo Jiang.   

Abstract

Wheat germ agglutinin (WGA) modified PEG-PLA nanoparticles (WGA-NP) have demonstrated its potential for enhancing delivery of peptides into brain following intranasal administration. However, the effect of ligand density is less well known. WGA density may affect nanoparticles uptake in nasal epithelial cells through ligand-receptor interactions, and the damage to nasal tissue since WGA showed cytotoxicity to cells in a dose-dependent manner. In this study, the effect of WGA density on WGA-NP was studied with regard to both the uptake and toxicity in vitro, using Calu-3 cells, which express a number of N-acetylglucosamine on their cell surface. Nanoparticles containing different WGA ligand densities were prepared by controlling the molar ratio of thiolated WGA to maleimide-PEG-PLA (WGA/maleimide) and particles properties were examined. With the increase of WGA/maleimide ratio, the particle size, WGA density and the hemoagglutination increased, while the conjugation efficiency decreased. The in vitro study showed markedly enhanced endocytosis of WGA-NP compared to NP in Calu-3 cells and significant inhibition of uptake in the presence of chitin. Cytotoxicity of WGA-NP increased gradually with the increase of molar ratio of WGA to maleimide, nanoparticles concentration and incubation time. WGA-NP showed the highest efficiency of uptake and a mild cytotoxicity when the molar ratio of WGA to maleimide was 1:10. These results suggest that WGA density plays an important role in both cellular uptake and toxicity of WGA-NP via a receptor-mediated mechanism. Therefore, to achieve a more rational approach of drug delivery system design, the surface density of the targeting moiety on the nanoparticles surface should be considered.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21550388     DOI: 10.1016/j.ijpharm.2011.04.026

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  7 in total

1.  A novel lectin from Agrocybe aegerita shows high binding selectivity for terminal N-acetylglucosamine.

Authors:  Shuai Jiang; Yijie Chen; Man Wang; Yalin Yin; Yongfu Pan; Bianli Gu; Guojun Yu; Yamu Li; Barry Hon Cheung Wong; Yi Liang; Hui Sun
Journal:  Biochem J       Date:  2012-04-15       Impact factor: 3.857

Review 2.  A Historical Review of Brain Drug Delivery.

Authors:  William M Pardridge
Journal:  Pharmaceutics       Date:  2022-06-16       Impact factor: 6.525

3.  Crystallization and preliminary crystallographic studies of AAL-2, a novel lectin from Agrocybe aegerita that binds nonreducing terminal N-acetylglucosamine.

Authors:  Xiaoming Ren; Shuai Jiang; Defeng Li; Hui Sun; Dacheng Wang
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-05-24

4.  Multi-functional Liposomes Enhancing Target and Antibacterial Immunity for Antimicrobial and Anti-Biofilm Against Methicillin-Resistant Staphylococcus aureus.

Authors:  Yansha Meng; Xucheng Hou; Jiongxi Lei; Mengmeng Chen; Shuangchen Cong; Yuanyuan Zhang; Weiming Ding; Guiling Li; Xinru Li
Journal:  Pharm Res       Date:  2015-12-14       Impact factor: 4.200

Review 5.  Brain Delivery of Nanomedicines: Trojan Horse Liposomes for Plasmid DNA Gene Therapy of the Brain.

Authors:  William M Pardridge
Journal:  Front Med Technol       Date:  2020-11-16

6.  A systematic in vitro investigation on poly-arginine modified nanostructured lipid carrier: Pharmaceutical characteristics, cellular uptake, mechanisms and cytotoxicity.

Authors:  Mingshuang Sun; Yunyun Gao; Zhihong Zhu; Huixin Wang; Cuiyan Han; Xinggang Yang; Weisan Pan
Journal:  Asian J Pharm Sci       Date:  2016-08-04       Impact factor: 6.598

Review 7.  Orally Administrable Therapeutic Nanoparticles for the Treatment of Colorectal Cancer.

Authors:  Kangkang Ying; Bingjun Bai; Xing Gao; Yuzi Xu; Hangxiang Wang; Binbin Xie
Journal:  Front Bioeng Biotechnol       Date:  2021-07-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.